Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study

被引：0

作者：

Perez de Prado, Armando ^{[1
]}

Cid, Belen ^{[2
]}

Carrillo Saez, Pilar ^{[3
]}

Diego, Alejandro ^{[4
]}

Cuellas, Carlos ^{[1
]}

Lopez-Otero, Diego ^{[2
]}

Cordero, Alberto ^{[3
]}

Lopez-Benito, Maria ^{[1
]}

Ocaranza-Sanchez, Raymundo ^{[2
]}

Rodriguez-Gabella, Tania ^{[4
]}

Frutos, Araceli ^{[3
]}

Estevez-Loureiro, Rodrigo ^{[1
]}

Merchan Gomez, Soraya ^{[4
]}

Trillo, Ramiro ^{[2
]}

Lopez Palop, Ramon ^{[3
]}

Fernandez-Vazquez, Felipe ^{[1
]}

机构：

[1] Hosp Univ Leon, Leon, Spain

[2] Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain

[3] Hosp Univ San Juan, Alicante, Spain

[4] Hosp Univ Salamanca, Salamanca, Spain

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-502

引用

页码：B148 / B148

页数：1

共 50 条

[1] Prasugrel or Clopidogrel in Patients With Acute Coronary Syndromes With Multivessel Disease: Results From the PROMETHEUS Study
Chiarito, Mauro
Pivato, Carlo Andrea
Cao, Davide
Zhang, Zhongjie
Sartori, Samantha
Nicolas, Johny
Nardin, Matteo
Kapadia, Samir
Weiss, Sandra
Rao, Sunil
Henry, Timothy
Effron, Mark
Weintraub, William
Pocock, Stuart
Dangas, George
Kini, Annapoorna
Mehran, Roxana
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B93 - B93
[2] Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland
Klingenberg, Roland
Heg, Dik
Raeber, Lorenz
Carballo, David
Nanchen, David
Gencer, Baris
Auer, Reto
Jaguszewski, Milosz
Staehli, Barbara E.
Jakob, Philipp
Templin, Christian
Stefanini, Giulio G.
Meier, Bernhard
Vogt, Pierre
Roffi, Marco
Maier, Willibald
Landmesser, Ulf
Rodondi, Nicolas
Mach, Francois
Windecker, Stephan
Jueni, Peter
Luescher, Thomas F.
Matter, Christian M.
HEART, 2015, 101 (11) : 854 - 863
[3] Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study
Chiarito, M.
Cao, D.
Zhongjie, Z.
Sartori, S.
Nicolas, J.
Nardin, M.
Pivato, C. A.
Tavenier, A.
Rao, S. V.
Henry, T. D.
Pocock, S.
Dangas, G.
Baber, U.
Kini, A.
Mehran, R.
EUROPEAN HEART JOURNAL, 2021, 42 : 1423 - 1423
[4] Switching Acute Coronary Syndrome Patients From Prasugrel to Clopidogrel
Kerneis, Mathieu
Silvain, Johanne
Abtan, Jeremie
Cayla, Guillaume
O'Connor, Stephen A.
Barthelemy, Olivier
Vignalou, Jean-Baptiste
Beygui, Farzin
Brugier, Delphine
Martin, Rejane
Collet, Jean-Philippe
Montalescot, Gilles
JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (02) : 158 - 165
[5] Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study
Chiarito, Mauro
Cao, Davide
Sartori, Samantha
Zhang, Zhongjie
Vogel, Birgit
Spirito, Alessandro
Smith, Kenneth F.
Weintraub, William
Strauss, Craig
Toma, Catalin
DeFranco, Anthony
Effron, Mark B.
Stefanini, Giulio
Keller, Stuart
Kapadia, Samir
Rao, Sunil, V
Henry, Timothy D.
Pocock, Stuart
Sharma, Samin
Dangas, George
Kini, Annapoorna
Baber, Usman
Mehran, Roxana
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2023, 12 (09) : 594 - 603
[6] PRASUGREL OR CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AT DIFFERENT THROMBOTIC RISK: RESULTS FROM THE PROMETHEUS STUDY
Chiarito, Mauro
Cao, Davide
Sartori, Samantha
Zhang, Zhongjie
Vogel, Birgit
Nicholas, Johny
Pivato, Carlo Andrea
Spirito, Alessandro
Tavenier, Annerieke
Effron, Mark
Stefanini, Giulio G.
Baber, Usman
Kapadia, Samir
Rao, Sunil
Henry, Timothy D.
Pocock, Stuart
Dangas, George
Kini, Annapoorna
Mehran, Roxana
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
[7] Ticagrelor and prasugrel versus clopidogrel in patients with acute coronary syndromes and chronic renal dysfunction: safety and efficacy
De Filippo, O.
D'Ascenzo, F.
Raposeiras-Roubin, S.
Peyracchia, M.
Gili, S.
Iannaccone, M.
Ariza-Sole, A.
Abu-Assi, E.
Liebetrau, C.
Manzano-Fernandez, S.
Montabone, A.
Henriques, J. P. S.
Quadri, G.
Giustetto, C.
Rinaldi, M.
EUROPEAN HEART JOURNAL, 2019, 40 : 4009 - 4009
[8] Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy
Ping-Yen Liu
Cheng-Huang Su
Feng-Yu Kuo
Wen-Lieng Lee
Yi-Chih Wang
Wei-Shiang Lin
Pao-Hsien Chu
Tse-Min Lu
Ping-Han Lo
Cheng-Han Lee
Wei-Ren Lan
Chien-Lung Huang
Shuji Tsukiyama
Wei-Chen Yang
Li-Chung Cheng
Virginia Rafael
Christian Nikolajsen
Wei-Hsian Yin
Cardiovascular Intervention and Therapeutics, 2022, 37 : 269 - 278
[9] Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy
Liu, Ping-Yen
Su, Cheng-Huang
Kuo, Feng-Yu
Lee, Wen-Lieng
Wang, Yi-Chih
Lin, Wei-Shiang
Chu, Pao-Hsien
Lu, Tse-Min
Lo, Ping-Han
Lee, Cheng-Han
Lan, Wei-Ren
Huang, Chien-Lung
Tsukiyama, Shuji
Yang, Wei-Chen
Cheng, Li-Chung
Rafael, Virginia
Nikolajsen, Christian
Yin, Wei-Hsian
CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (02) : 269 - 278
[10] Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study
Angiolillo, Dominick J.
Saucedo, Jorge F.
DeRaad, Roger
Frelinger, Andrew L.
Gurbel, Paul A.
Costigan, Timothy M.
Jakubowski, Joseph A.
Ojeh, Clement K.
Effron, Mark B.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : 1017 - 1023

← 1 2 3 4 5 →